Effect of Intravitreal Methotrexate and Rituximab on Interleukin-10 Levels in Aqueous Humor of Treated Eyes with Vitreoretinal Lymphoma

• Harish Raja,

  Affiliation Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Melissa R. Snyder,

  Affiliation Department of Laboratory Medicine and Pathology, Antibody Immunology Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Patrick B. Johnston,

  Affiliation Department of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Brian P. O’Neill,

  Affiliation Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Juline N. Caraballo,

  Affiliation Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Joseph G. Balsanek,

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Brian E. Peters,

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Paul A. Decker,

  Affiliation Department of Biomedical Statistics, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Jose S. Pulido

  * E-mail: pulido.jose@mayo.edu

  Affiliation Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯